Renal Cell Carcinoma (RCC) Clinical Trials

Find Renal Cell Carcinoma (RCC) Clinical Trials Near You

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI....

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: t
View:

• Individuals with biopsy-proven malignant disease

• Individuals suspected of having a malignant disease

• Individuals who have or are suspected of having an inherited genitourinary malignant disorder

• Participants must be \>= 2 years of age

• A relative (related by blood) of an individual with a confirmed or suspected diagnosis of a malignant disease or an inherited genitourinary malignant disorder.

• All participants and parents/guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed.

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Deborah A Nielsen, R.N.
deborah.nielsen@nih.gov
(240) 760-6247
Backup
W. Marston Linehan, M.D.
linehanm@mail.nih.gov
(240) 858-3700
Time Frame
Start Date: 1998-03-12
Participants
Target number of participants: 5950
Treatments
Family Members
Family members (related by blood) of participants who have or are suspected of having a malignant disease or an inherited genitourinary malignant disorder
Participants
Participants with biopsy-proven malignant diseases; or participants suspected of having a malignant disease; or participants who have or who are suspected of having an inherited genitourinary malignant disorder
Sponsors
Leads: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov